Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Original ArticlesClinical Nephrology
You have accessRestricted Access

Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Eugene P. Rhee, Karen A. Laliberte and John L. Niles
CJASN August 2010, 5 (8) 1394-1400; DOI: https://doi.org/10.2215/CJN.08821209
Eugene P. Rhee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen A. Laliberte
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John L. Niles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Article Information

vol. 5 no. 8 1394-1400
DOI 
https://doi.org/10.2215/CJN.08821209
PubMed 
20498238

Published By 
American Society of Nephrology
Print ISSN 
1555-9041
Online ISSN 
1555-905X
History 
  • Received December 8, 2009
  • Accepted April 13, 2010
  • Published online August 6, 2010.

Article Versions

  • Earlier version (May 24, 2010 - 06:55).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2010 by the American Society of Nephrology

Author Information

  1. Eugene P. Rhee,
  2. Karen A. Laliberte,
  3. John L. Niles
  1. Renal Unit, Massachusetts General Hospital, Boston, Massachusetts
  1. Correspondence:
    Dr. John L. Niles, Renal Unit, Massachusetts General Hospital, 151 Merrimac Street, 3rd floor, Boston, MA 02114. Phone: 617-726-1108; Fax: 617-248-3884; E-mail: jniles{at}partners.org
View Abstract

Statistics from Altmetric.com

Article usage

Article usage: May 2010 to December 2020

AbstractFullPdf
May 201055033
Jun 201074050
Jul 201028024
Aug 201040068268
Sep 201020034143
Oct 20101216069
Nov 20101733062
Dec 2010239824
Jan 2011177628
Feb 2011138718
Mar 20111951016
Apr 2011132513
May 20111691928
Jun 201186820
Jul 20111231019
Aug 20111774964
Sep 20111226135
Oct 20111195746
Nov 2011964543
Dec 2011816145
Jan 20121234847
Feb 20121024030
Mar 20121274759
Apr 20121526761
May 20121275850
Jun 20121266041
Jul 20121625657
Aug 20121044241
Sep 20121384948
Oct 20121314148
Nov 20121643863
Dec 20121263347
Jan 20131544446
Feb 20131344237
Mar 20131302426
Apr 20131443948
May 20131612841
Jun 2013832419
Jul 20131173538
Aug 2013601925
Sep 2013883342
Oct 2013791827
Nov 2013862319
Dec 2013741924
Jan 2014842518
Feb 2014772325
Mar 20141021642
Apr 20141281522
May 20141202230
Jun 2014941332
Jul 20141111828
Aug 2014602122
Sep 2014883141
Oct 2014632111
Nov 2014503010
Dec 2014441010
Jan 2015622317
Feb 2015742126
Mar 20151031416
Apr 2015822318
May 2015851012
Jun 2015651411
Jul 2015631222
Aug 201557911
Sep 2015851115
Oct 20151091921
Nov 201570149
Dec 20159499
Jan 2016781514
Feb 201660155
Mar 20161424912
Apr 2016571610
May 2016681514
Jun 2016841920
Jul 2016971723
Aug 2016641120
Sep 201646837
Oct 2016611010
Nov 2016541014
Dec 201645274
Jan 2017411714
Feb 2017561211
Mar 201743166
Apr 20173294
May 201767117
Jun 201749137
Jul 201727136
Aug 201741189
Sep 201733126
Oct 20174294
Nov 20175395
Dec 201749117
Jan 2018741012
Feb 201834154
Mar 2018381211
Apr 2018371217
May 20183155
Jun 201838116
Jul 20183465
Aug 2018271711
Sep 201811146
Oct 201873613
Nov 201884210
Dec 201883610
Jan 201982712
Feb 201973510
Mar 201972611
Apr 20198228
May 20194166
Jun 201931612
Jul 201992821
Aug 20190217
Sep 201982513
Oct 201913196
Nov 201991916
Dec 201911167
Jan 202061411
Feb 20207167
Mar 202042113
Apr 202054614
May 202051912
Jun 2020124711
Jul 20204342
Aug 202031216
Sep 2020103411
Oct 20202619
Nov 20206283
Dec 20203422

Cited By...

  • 82 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Clinical Journal of the American Society of Nephrology
Vol. 5, Issue 8
1 Aug 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in CJASN.
Enter multiple addresses on separate lines or separate them with commas.
Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Eugene P. Rhee, Karen A. Laliberte, John L. Niles
CJASN Aug 2010, 5 (8) 1394-1400; DOI: 10.2215/CJN.08821209

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Eugene P. Rhee, Karen A. Laliberte, John L. Niles
CJASN Aug 2010, 5 (8) 1394-1400; DOI: 10.2215/CJN.08821209
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

Original Articles

  • Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States
  • Availability, Accessibility, and Quality of Conservative Kidney Management Worldwide
  • Zolpidem Versus Trazodone Initiation and the Risk of Fall-Related Fractures among Individuals Receiving Maintenance Hemodialysis
Show more Original Articles

Clinical Nephrology

  • Systematic Review and Meta-Analysis of Native Kidney Biopsy Complications
  • Major Bleeding and Risk of Death after Percutaneous Native Kidney Biopsies
  • COVID-19 Outbreak and Management Approach for Families with Children on Long-Term Kidney Replacement Therapy
Show more Clinical Nephrology

Cited By...

  • The Search for a Biomarker of Relapse in ANCA-Associated Vasculitis
  • Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions
  • Long-Term Maintenance Therapy Using Rituximab-Induced Continuous B-Cell Depletion in Patients with ANCA Vasculitis
  • Documentation of off-label use of biologics in Rheumatoid Arthritis
  • Could we abandon cyclophosphamide in systemic vasculitis and lupus nephritis?
  • Decreased CD5+ B Cells in Active ANCA Vasculitis and Relapse after Rituximab
  • Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
  • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011
  • B Cell Strategy to Maintain Remission in ANCA-associated Vasculitides?
  • Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry
  • Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic Polyangiitis
  • Rituximab Treatment for Vasculitis
  • Google Scholar

Similar Articles

Related Articles

  • Rituximab Treatment for Vasculitis
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe

© 2021 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire